Pharmacology Futures 2018 Abstracts deadline: 2 March 2018 Registration deadline: 10 May 2018 Professor Dame Sally Davies - Building and maintaining a global response to AMR Sally Davies will be closing the Pharmacology Futures 2018 conference with the 2017 Cameron Prize for Therapeutics lecture. Although registration for the main meeting is now closed, the organisers have made 25 places available at £20 for people who just want to hear Sally speak. The lecture is scheduled to start at 4.30 pm. If you wish to attend please email Charlotte Cordrey the British Pharmacology Society. Email Charlotte Cordrey Please note: Attendees for Sally's lecture will only be able to access the lecture at the following times: Arrive during the 3.20 - 3.50 pm refreshment break and sit in the talks of Session 4 and Professor Dame Sally Davies or arrive no later than 4.10 pm where they will be able to enter just before Professor Dame Sally Davies starts talking. People will not be able to access the lecture theatre after she has started speaking. Meeting aims To understand the role of structural genomics in generating and testing small molecule inhibitors To appreciate the importance of epigenetics as a target for drug discovery To recognise the role of stem cells in therapeutics, drug safety pharmacology, and drug discovery To appreciate the use of biomarkers in guiding therapy To understand the importance of allosteric drug binding sites for novel drug development To describe trans-institute approaches to drug development for neurological diseases, using the National Institute of Mental Health as an example Speakers Professor Chas Bountra Structural Genomics Consortium, University of Oxford, UK and Former VP and Head of Biology, GlaxoSmithKline Professor Mark Nelson Chair and University Distinguished Professor, Department of Pharmacology, University of Vermont, USA and Member of the Editorial Board of the Annual Review of Pharmacology and Toxicology Professor Christine Mummery Chair of the Department of Anatomy and Embryology, Leiden University Medical Centre, The Netherlands Dr James Dear Reader in Clinical Pharmacology, University of Edinburgh, UK Professor Susan Amara Scientifc Director, National Institute of Mental Health, USA and Associate Editor, Editorial Board of the Annual Review of Pharmacology and Toxicology Professor Arthur Christopoulos Professor of Pharmacology and NHMRC Principal Research Fellow, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia Dr Rab Prinjha Vice-President, Head of Epinova Epigenetics Discovery Performance Unit, GlaxoSmithKlineProfessor Dame Professor Dame Sally Davies Chief Medical Officer for England, Department of Health, UK Local organisers Professor Michael Eddleston Professor of Clinical Toxicology, Pharmacology, Toxicology and Therapeutics, University of Edinburgh, UK Professor David Webb President, British Pharmacological Society and Christison Professor of Therapeutics and Clinical Pharmacology, University of Edinburgh, UK May 17 2018 00.00 - 00.00 Pharmacology Futures 2018 Celebrating 250 years of pharmacology in Edinburgh Pharmacology Futures 2018 will explore the technologies and skills that will drive drug development over the next 10 to 15 years. National Museum of Scotland Chambers Street Edinburgh EH1 1JF More details and registration
Pharmacology Futures 2018 Abstracts deadline: 2 March 2018 Registration deadline: 10 May 2018 Professor Dame Sally Davies - Building and maintaining a global response to AMR Sally Davies will be closing the Pharmacology Futures 2018 conference with the 2017 Cameron Prize for Therapeutics lecture. Although registration for the main meeting is now closed, the organisers have made 25 places available at £20 for people who just want to hear Sally speak. The lecture is scheduled to start at 4.30 pm. If you wish to attend please email Charlotte Cordrey the British Pharmacology Society. Email Charlotte Cordrey Please note: Attendees for Sally's lecture will only be able to access the lecture at the following times: Arrive during the 3.20 - 3.50 pm refreshment break and sit in the talks of Session 4 and Professor Dame Sally Davies or arrive no later than 4.10 pm where they will be able to enter just before Professor Dame Sally Davies starts talking. People will not be able to access the lecture theatre after she has started speaking. Meeting aims To understand the role of structural genomics in generating and testing small molecule inhibitors To appreciate the importance of epigenetics as a target for drug discovery To recognise the role of stem cells in therapeutics, drug safety pharmacology, and drug discovery To appreciate the use of biomarkers in guiding therapy To understand the importance of allosteric drug binding sites for novel drug development To describe trans-institute approaches to drug development for neurological diseases, using the National Institute of Mental Health as an example Speakers Professor Chas Bountra Structural Genomics Consortium, University of Oxford, UK and Former VP and Head of Biology, GlaxoSmithKline Professor Mark Nelson Chair and University Distinguished Professor, Department of Pharmacology, University of Vermont, USA and Member of the Editorial Board of the Annual Review of Pharmacology and Toxicology Professor Christine Mummery Chair of the Department of Anatomy and Embryology, Leiden University Medical Centre, The Netherlands Dr James Dear Reader in Clinical Pharmacology, University of Edinburgh, UK Professor Susan Amara Scientifc Director, National Institute of Mental Health, USA and Associate Editor, Editorial Board of the Annual Review of Pharmacology and Toxicology Professor Arthur Christopoulos Professor of Pharmacology and NHMRC Principal Research Fellow, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia Dr Rab Prinjha Vice-President, Head of Epinova Epigenetics Discovery Performance Unit, GlaxoSmithKlineProfessor Dame Professor Dame Sally Davies Chief Medical Officer for England, Department of Health, UK Local organisers Professor Michael Eddleston Professor of Clinical Toxicology, Pharmacology, Toxicology and Therapeutics, University of Edinburgh, UK Professor David Webb President, British Pharmacological Society and Christison Professor of Therapeutics and Clinical Pharmacology, University of Edinburgh, UK May 17 2018 00.00 - 00.00 Pharmacology Futures 2018 Celebrating 250 years of pharmacology in Edinburgh Pharmacology Futures 2018 will explore the technologies and skills that will drive drug development over the next 10 to 15 years. National Museum of Scotland Chambers Street Edinburgh EH1 1JF More details and registration
May 17 2018 00.00 - 00.00 Pharmacology Futures 2018 Celebrating 250 years of pharmacology in Edinburgh Pharmacology Futures 2018 will explore the technologies and skills that will drive drug development over the next 10 to 15 years.
